Healthcare Trust of America, Inc. (NYSE:HTA) has earned a consensus rating of “Buy” from the thirteen ratings firms that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12-month price target among brokers that have covered the stock in the last year is $34.50.

Several brokerages have recently commented on HTA. Zacks Investment Research raised Healthcare Trust of America from a “sell” rating to a “hold” rating in a research report on Tuesday, September 12th. BidaskClub cut Healthcare Trust of America from a “hold” rating to a “sell” rating in a research report on Monday, July 31st. BMO Capital Markets raised Healthcare Trust of America from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $33.00 to $35.00 in a research report on Tuesday, June 20th. They noted that the move was a valuation call. Wells Fargo & Company reaffirmed an “outperform” rating and issued a $35.00 target price (up previously from $33.50) on shares of Healthcare Trust of America in a research report on Friday, June 16th. Finally, TheStreet cut Healthcare Trust of America from a “b-” rating to a “c” rating in a research report on Monday, July 31st.

In related news, CEO Scott D. Peters sold 55,240 shares of the stock in a transaction on Tuesday, June 27th. The stock was sold at an average price of $32.06, for a total transaction of $1,770,994.40. Following the completion of the sale, the chief executive officer now directly owns 405,092 shares in the company, valued at $12,987,249.52. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 1.50% of the stock is currently owned by company insiders.

Several large investors have recently made changes to their positions in HTA. Henderson Group PLC raised its holdings in shares of Healthcare Trust of America by 9.1% during the first quarter. Henderson Group PLC now owns 22,390 shares of the real estate investment trust’s stock worth $704,000 after acquiring an additional 1,867 shares in the last quarter. BNP Paribas Arbitrage SA raised its holdings in shares of Healthcare Trust of America by 278.4% during the first quarter. BNP Paribas Arbitrage SA now owns 54,549 shares of the real estate investment trust’s stock worth $1,716,000 after acquiring an additional 40,132 shares in the last quarter. Comerica Bank purchased a new stake in shares of Healthcare Trust of America during the first quarter worth $202,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Healthcare Trust of America by 6.0% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,523 shares of the real estate investment trust’s stock worth $268,000 after acquiring an additional 485 shares in the last quarter. Finally, Swiss National Bank raised its holdings in shares of Healthcare Trust of America by 3.0% during the first quarter. Swiss National Bank now owns 233,586 shares of the real estate investment trust’s stock worth $7,349,000 after acquiring an additional 6,800 shares in the last quarter. Institutional investors and hedge funds own 97.75% of the company’s stock.

Healthcare Trust of America (NYSE HTA) traded down 1.01% during trading on Friday, reaching $30.36. The company had a trading volume of 1,101,529 shares. The company has a 50-day moving average price of $30.54 and a 200 day moving average price of $31.00. The stock has a market cap of $6.09 billion, a PE ratio of 148.82 and a beta of 0.32. Healthcare Trust of America has a 52-week low of $26.34 and a 52-week high of $34.35.

Healthcare Trust of America (NYSE:HTA) last issued its earnings results on Monday, July 31st. The real estate investment trust reported $0.39 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.39. The business had revenue of $139.90 million during the quarter, compared to analysts’ expectations of $133.69 million. Healthcare Trust of America had a return on equity of 1.42% and a net margin of 6.07%. Healthcare Trust of America’s revenue was up 23.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.38 earnings per share. On average, analysts anticipate that Healthcare Trust of America will post $0.26 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 6th. Investors of record on Monday, October 2nd will be issued a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a dividend yield of 4.02%. This is a positive change from Healthcare Trust of America’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Friday, September 29th. Healthcare Trust of America’s dividend payout ratio (DPR) is currently 571.43%.

ILLEGAL ACTIVITY WARNING: This story was first posted by Daily Political and is owned by of Daily Political. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at https://www.dailypolitical.com/2017/09/20/analysts-set-healthcare-trust-of-america-inc-hta-price-target-at-34-50.html.

Healthcare Trust of America Company Profile

Healthcare Trust of America, Inc is a real estate investment trust. The Company is an owner and operator of medical office buildings (MOBs) in the United States. The Company focuses on owning and operating MOBs that serve healthcare delivery and are located on health system campuses, near university medical centers, or in community core outpatient locations.

Analyst Recommendations for Healthcare Trust of America (NYSE:HTA)

Receive News & Ratings for Healthcare Trust of America Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Trust of America Inc. and related companies with MarketBeat.com's FREE daily email newsletter.